Received: 7 June 2021
Accepted: 8 October 2021
First Online: 25 October 2021
: Institutional Review Board approval of the study protocol was obtained prior to study conduct from the WCG IRB, and included a waiver of informed consent, in accordance with relevant ethical guidelines (Declaration of Helsinki).
: Not applicable.
: At the time of the study, AS, BS, JS, OH, MM, report employment in Flatiron Health, Inc., an independent subsidiary of Roche. AS, BS, JS, OH, MM report stock ownership in Roche. BS, JS report equity ownership in Flatiron Health, Inc.